Free shipping on all orders over $ 500

Vepdegestrant (ARV-471)

Cat. No. M21158

All AbMole products are for research use only, cannot be used for human consumption.

Vepdegestrant (ARV-471) Structure
Synonym:

ARV471; PF-07850327

Size Price Availability Quantity
1mg USD 260  USD260 In stock
5mg USD 620  USD620 In stock
10mg USD 850  USD850 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Vepdegestrant (ARV-471) is an oral estrogen receptor PROTAC protein degrader for breast cancer. Vepdegestrant (ARV-471) is a heterobifunctional molecule that promotes the interaction between estrogen receptor alpha and intracellular E3 ligase complexes. Vepdegestrant (ARV-471) causes ubiquitination and subsequent degradation of the estrogen receptor via the proteasome. Vepdegestrant (ARV-471) potently degrades ER-positive The ER in breast cancer cell lines is potently degraded by ARV-471 with a DC50 value of approximately 2 nM.

Chemical Information
Molecular Weight 723.9
Formula C45H49N5O4
CAS Number 2229711-68-4
Solubility (25°C) DMSO 90 mg/mL
Storage -20°C, protect from light, dry, sealed
References

[1] Jia-Yue Xi, et al. Bioorg Chem. Advances and perspectives of proteolysis targeting chimeras (PROTACs) in drug discovery

[2] Diego Garcia Jimenez, et al. ADMET DMPK. Are we ready to design oral PROTACs®?

[3] Hui Qin, et al. Curr Med Chem. Overview of PROTACs Targeting the Estrogen Receptor: Achievements for Biological and Drug Discovery

[4] Chao Wang, et al. Eur J Med Chem. Developments of CRBN-based PROTACs as potential therapeutic agents

[5] Si-Min Qi, et al. Front Pharmacol. PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy

Related PROTAC Products
MS4322

MS4322 (YS43-22) is a specific PRMT5 PROTAC degrader. MS4322 reduces the PRMT5 protein level with a DC50 of 1.1 μM in MCF-7 cells. MS4322 inhibits the methyltransferase activity of PRMT5 with an IC50 of 18 nM. MS4322 promotes ubiquitination and degradation of PRMT5.

xStAx-VHLL TFA

xStAx-VHLL TFA, a PROTAC, sustains β-catenin degradation and manifested strong inhibition of Wnt signaling. xStAx-VHLL TFA promotes β-catenin ubiquitination.

(S,R,S)-AHPC-C2-amide-benzofuranylmethyl-pyridine

(S,R,S)-AHPC-C2-amide-benzofuranylmethyl-pyridine is a dual target PROTAC that can not only target to the ubiquitination and degradation of Smad3 but also improve the HIF-α protein level.

MTX-23

MTX-23 is an AR-based PROTAC. MTX-23 inhibits CaP cellular proliferation by degrading AR-V7 and AR-FL. MTX-23 induces apoptosis.

YD23 

YD23 is a SMARCA2 PROTAC.

  Catalog
Abmole Inhibitor Catalog




Keywords: Vepdegestrant (ARV-471), ARV471; PF-07850327 supplier, PROTAC, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.